- Home
- BWFG vs AGMB Comparison
BWFG vs AGMB Comparison
Compare BWFG & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BWFG | AGMB |
|---|---|---|
| Founded | 2002 | 2017 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 525.2M | 576.2M |
| IPO Year | 2014 | 2024 |
Fundamental Metrics
Financial Performance| Metric | BWFG | AGMB |
|---|---|---|
| Price | $65.27 | $8.92 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $69.50 | $37.67 |
| AVG Volume (30 Days) | 56.6K | ★ 139.6K |
| Earning Date | 10-22-2026 | 11-14-2026 |
| Dividend Yield | ★ 1.24% | N/A |
| EPS Growth | ★ 261.79 | N/A |
| EPS | ★ 2.95 | N/A |
| Revenue | ★ $2,826,000.00 | N/A |
| Revenue This Year | $20.01 | N/A |
| Revenue Next Year | $6.51 | N/A |
| P/E Ratio | $22.00 | ★ N/A |
| Revenue Growth | ★ 43.96 | N/A |
| 52 Week Low | $40.45 | $8.75 |
| 52 Week High | $69.59 | $17.82 |
Technical Indicators
Market Signals| Indicator | BWFG | AGMB |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 40.11 |
| Support Level | N/A | $10.17 |
| Resistance Level | N/A | $12.53 |
| Average True Range (ATR) | 0.00 | 0.92 |
| MACD | 0.00 | -0.12 |
| Stochastic Oscillator | 0.00 | 32.55 |
Price Performance
Historical ComparisonAbout BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
About AGMB AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.